Meeting News

Nivolumab-ipilimumab combination confers durable OS, PFS benefit in metastatic melanoma

October 7, 2019
BARCELONA, Spain — The combination of nivolumab and ipilimumab improved long-term survival compared with either of the immunotherapy drugs…
Meeting News

Circulating tumor DNA ‘a major prognostic factor’ in colorectal cancer

October 4, 2019
BARCELONA, Spain — Circulating tumor DNA detected through liquid biopsy appeared to be an independent prognostic marker for identifying…